# Yutaka Niihara, M.D., MPH – FDA Inspection, Feb 13, 2017

Source: https://www.keypedia.com/records/fda_inspections/yutaka-niihara-md-mph/f1357a02-e86c-403a-bd23-7033167cb31e
Source feed: FDA_Inspections

> FDA inspection 1002331 of Yutaka Niihara, M.D., MPH, February 13, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1002331
- Company Name: Yutaka Niihara, M.D., MPH
- Inspection Date: 2017-02-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Officers

- [Company Rep](https://www.keypedia.com/people/diane-c-van-leeuwen/98af0d70-2db1-4132-8193-fcccf8841960)

Company: https://www.keypedia.com/companies/yutaka-niihara-md-mph/ba33e2eb-6e7e-4854-8189-45afaa422e95

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c